Bioequivalence Study of BAY77-1931 Granule
NCT01053676
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperphosphatemia
Interventions
DRUG:
Lanthanum Carbonate (Fosrenol, BAY77-1931) Granule
DRUG:
Lanthanum Carbonate (Fosrenol, BAY77-1931) Chewable tablet
Sponsor
Bayer